The data of subsequent analysis showed that high SLC25A21‐AS1 expression was associated with poor prognosis, late N stage, and poor tumour grade in 67 ESCC patients tested using cDNA microarrays (Figure 8C–E). The gene discussed is SLC25A21; the disease is neoplasm.